Moleculin Biotech
MBRX
MBRX
24 hedge funds and large institutions have $8.57M invested in Moleculin Biotech in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$107K | |
| 2 | +$61K | |
| 3 | +$24K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.6K |
| 5 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$7K |
Top Sellers
| 1 | -$140K | |
| 2 | -$121K | |
| 3 | -$114K | |
| 4 |
Goldman Sachs
New York
|
-$94K |
| 5 |
VF
Virtu Financial
New York
|
-$93K |